|
Valeramol
|
200 mg/g
|
V/DCP/23/0061
|
Pharmanovo Veterinärarzneimittel GmbH, Austrija
|
QN02BE01
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0061-01 |
|
1 |
Maiss, 1 kg |
-
|
| V/DCP/23/0061-02 |
|
1 |
Maiss, 6 kg |
-
|
| V/DCP/23/0061-03 |
|
10 |
ABPE pudele, 150 g |
-
|
|
|
Orilane
|
-
|
V/SRP/23/0045
|
Chanelle Pharmaceuticals Manufacturing Limited, Īrija
|
QS02CA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/SRP/23/0045-01 |
|
1 |
PET pudele (balta), 15 ml |
-
|
| V/SRP/23/0045-02 |
|
1 |
PET pudele (balta), 30 ml |
-
|
|
|
Gallifen
|
200 mg/ml
|
V/DCP/18/0009
|
Huvepharma NV, Beļģija
|
QP52AC13
|
pheasants; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0009-01 |
|
1 |
ABPE pudele, 125 ml |
-
|
| V/DCP/18/0009-02 |
|
1 |
ABPE pudele (cilindriska), 1 l |
-
|
| V/DCP/18/0009-03 |
|
1 |
Polietilēna kanna, 2,5 l |
-
|
| V/DCP/18/0009-04 |
|
1 |
Polietilēna kanna, 5 l |
-
|
| V/DCP/18/0009-05 |
|
1 |
ABPE pudele (taisnstūrveida), 1 l |
-
|
|
|
Dormostart
|
1 mg/ml
|
V/DCP/23/0062
|
Alfasan Nederland BV, Nīderlande
|
QN05CM91
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0062-01 |
|
1 |
Stikla flakons, 5 ml |
-
|
| V/DCP/23/0062-02 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/23/0062-03 |
|
1 |
Stikla flakons, 20 ml |
-
|
|
|
Drontal
|
230.20 mg/mg
|
V/NRP/99/0981
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Praziquantel, Pyrantel embonate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
KVP Pharma und Veterinär - Produkte GmbH, Vācija;Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
30-Apr-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 31012025LI (31-Jan-2025)
|
| Labelling text: |
[DOCX] 23102020M (23-Oct-2020)
|
| Summary of product characteristics: |
[DOCX] 31012025ZA (31-Jan-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/99/0981-02 |
|
24 |
Blisteris, 1 tablete |
-
|
| V/NRP/99/0981-04 |
|
2 |
Blisteris, 1 tablete |
-
|
|
|
Trilotab vet
|
150 mg
|
V/DCP/23/0043
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0043-01 |
|
3 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
| V/DCP/23/0043-02 |
|
10 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
|
|
HuveGuard NB
|
-
|
V/MRP/16/0012
|
Huvepharma NV, Beļģija
|
QI01AN01
|
chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/16/0012-01 |
|
1 |
ZBPE flakons, 1000 deva |
-
|
| V/MRP/16/0012-02 |
|
5 |
ZBPE flakons, 1000 deva |
-
|
| V/MRP/16/0012-03 |
|
10 |
ZBPE flakons, 1000 deva |
-
|
| V/MRP/16/0012-04 |
|
1 |
ZBPE flakons, 5000 deva |
-
|
| V/MRP/16/0012-05 |
|
5 |
ZBPE flakons, 5000 deva |
-
|
| V/MRP/16/0012-06 |
|
10 |
ZBPE flakons, 5000 deva |
-
|
|
|
Doxx-Sol
|
500 mg/g
|
V/DCP/14/0072
|
Huvepharma NV, Beļģija
|
QJ01AA02
|
pigs; chickens; pre-ruminant cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0072-01 |
500 mg/g |
1 |
Al/PE paciņa, 1 kg |
-
|
| V/DCP/14/0072-02 |
500 mg/g |
1 |
Al/PE paciņa, 5 kg |
-
|
|
|
CYLANIC
|
-
|
V/DCP/21/0040
|
Industrial Veterinaria, S.A., Spānija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;Lelypharma B.V., Nīderlande;aniMedica Herstellungs GmbH, Vācija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 24102025LI (24-Oct-2025)
|
| Labelling text: |
[DOCX] 24102025M (24-Oct-2025)
|
| Summary of product characteristics: |
[DOCX] 24102025ZA (24-Oct-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0040-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-02 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-03 |
|
5 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-04 |
|
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-05 |
|
25 |
Blisteris, 10 tablete |
-
|
|
|
WERAVET 12 Sabinapuersal
|
-
|
V/H/21/0044
|
Biokanol Pharma GmbH, Vācija
|
QV03AX
|
cattle; pigs; sheep; goats; horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Juniperus sabina
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Biokanol Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
30-Jun-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
H
|
| Package leaflet: |
[DOCX] 30062021LI (30-Jun-2021)
|
| Labelling text: |
[DOCX] 30062021M (30-Jun-2021)
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/H/21/0044-01 |
|
20 |
Stikla ampula, 2 ml |
-
|
|
|
Sympagesic 500 mg/ml + 4 mg/ml
|
-
|
V/DCP/19/0030
|
Dechra Regulatory B.V., Nīderlande
|
QA03DB04
|
cattle; pigs; horses; dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Metamizole sodium monohydrate, Hyoscine butylbromide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 290620LI (29-Jun-2020)
|
| Labelling text: |
[DOCX] 290620M (29-Jun-2020)
|
| Summary of product characteristics: |
[DOCX] 04062019ZA (04-Jun-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0030-01 |
500 mg/4 ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/19/0030-02 |
500 mg/4 ml |
5 |
Stikla flakons, 100 ml |
-
|
|
|
Propodine
|
-
|
V/DCP/19/0037
|
Dechra Regulatory B.V., Nīderlande
|
QN01AX10
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Propofol
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
CORDEN PHARMA S.p.A., Itālija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 01072019_LI (01-Jul-2019)
|
| Labelling text: |
[PDF] 01072019_M (01-Jul-2019)
|
| Summary of product characteristics: |
[PDF] 01072019_ZA (01-Jul-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0037-01 |
10 mg/ml |
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/19/0037-02 |
10 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/19/0037-03 |
10 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Dexa-ject
|
2 mg/ml
|
V/DCP/12/0053
|
Dopharma Research B.V., Nīderlande
|
QH02AB02
|
cattle; pigs; horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dexamethasone sodium phosphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dopharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
31-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 280717LI (31-Jul-2017)
|
| Labelling text: |
[PDF] 280717M (31-Jul-2017)
|
| Summary of product characteristics: |
[PDF] 280717ZA (31-Jul-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/12/0053-01 |
2 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/12/0053-02 |
2 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
PERMAWAY
|
600 mg
|
V/DCP/20/0065
|
Vetoquinol S.A., Francija
|
QJ51CF02
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Cloxacillin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol Biowet Sp. z o.o., Polija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 18122020LI (18-Dec-2020)
|
| Labelling text: |
[DOCX] 18122020M (18-Dec-2020)
|
| Summary of product characteristics: |
[DOCX] 18122020ZA (18-Dec-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0065-01 |
600 mg |
24 |
Injektors, 3,6 g |
-
|
| V/DCP/20/0065-02 |
600 mg |
48 |
Injektors, 3,6 g |
-
|
| V/DCP/20/0065-03 |
600 mg |
96 |
Injektors, 3,6 g |
-
|
|
|
Raboral V-RG
|
-
|
V/NRP/03/1613
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QI07BD
|
foxes
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
bait
|
| International name (active substance): |
Rabies virus glycoproteins
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS, Francija
|
| Date of authorisation/renewal: |
08-Dec-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 180920LI (18-Sep-2020)
|
| Labelling text: |
[DOCX] 280720M (28-Jul-2020)
|
| Summary of product characteristics: |
[DOCX] 280720ZA (28-Jul-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/03/1613-01 |
|
200 |
Maisiņš (polistirēna kastē), 1 deva |
-
|
| V/NRP/03/1613-02 |
|
200 |
Maisiņš (polietilēna maisā), 1 deva |
-
|
|
|
HatchPak IB H120
|
-
|
V/DCP/08/1603
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
frozen suspension for oculonasal use
|
| International name (active substance): |
Attenuated live virus of avian infectious bronchitis, Massachusetts serotype, strain H-120
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS, Francija
|
| Date of authorisation/renewal: |
14-Aug-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (07-Jun-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (07-Jun-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (07-Jun-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/08/1603-01 |
|
4 |
Ampula, 10000 deva |
-
|
| V/DCP/08/1603-02 |
|
4 |
Ampula, 15000 deva |
-
|
|
|
Cestal Cat 80/20 mg
|
-
|
V/DCP/17/0019
|
Ceva Sante Animale,, Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Praziquantel,Pyrantel
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Lavet Pharmaceuticals, Ungārija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 230320LI (23-Mar-2020)
|
| Labelling text: |
[PDF] 230320M (23-Mar-2020)
|
| Summary of product characteristics: |
[PDF] 230320ZA (23-Mar-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0019-01 |
1 mg |
1 |
Al/PE blisteris, 2 tablete |
-
|
| V/DCP/17/0019-02 |
1 mg |
2 |
Al/PE blisteris, 2 tablete |
-
|
| V/DCP/17/0019-03 |
1 mg |
52 |
Al/PE blisteris, 2 tablete |
-
|
| V/DCP/17/0019-04 |
1 mg |
1 |
Al/PE blisteris, 8 tablete |
-
|
| V/DCP/17/0019-05 |
1 mg |
3 |
Al/PE blisteris, 8 tablete |
-
|
| V/DCP/17/0019-06 |
1 mg |
6 |
Al/PE blisteris, 8 tablete |
-
|
| V/DCP/17/0019-07 |
1 mg |
13 |
Al/PE blisteris, 8 tablete |
-
|
| V/DCP/17/0019-08 |
1 mg |
5 |
Al/PE blisteris, 2 tablete |
-
|
| V/DCP/17/0019-09 |
1 mg |
25 |
Al/PE blisteris, 2 tablete |
-
|
|
|
Porceptal
|
4 µg/ml
|
V/DCP/13/0041
|
Intervet International B.V., Nīderlande
|
QH01CA90
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Buserelin acetate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International GmbH, Vācija
|
| Date of authorisation/renewal: |
31-Oct-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 30102018LI (30-Oct-2018)
|
| Labelling text: |
[DOCX] 30102018M (30-Oct-2018)
|
| Summary of product characteristics: |
[PDF] 30102018ZA (30-Oct-2018)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/13/0041-01 |
4 µg/ml |
10 |
Stikla flakons, 2,5 ml |
-
|
| V/DCP/13/0041-02 |
4 µg/ml |
10 |
Stikla flakons, 5 ml |
-
|
| V/DCP/13/0041-03 |
4 µg/ml |
5 |
Stikla flakons, 10 ml |
-
|
| V/DCP/13/0041-04 |
4 µg/ml |
1 |
Stikla flakons, 5 ml |
-
|
| V/DCP/13/0041-05 |
4 µg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/13/0041-06 |
4 µg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Enzaprost
|
5 mg/ml
|
V/MRP/12/0054
|
Ceva Sante Animale', Francija
|
QG02AD01
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/12/0054-01 |
5 mg/ml |
10 |
Stikla flakons, 5 ml |
-
|
| V/MRP/12/0054-02 |
5 mg/ml |
5 |
Stikla flakons, 10 ml |
-
|
| V/MRP/12/0054-03 |
5 mg/ml |
1 |
Stikla flakons, 30 ml |
-
|
| V/MRP/12/0054-04 |
5 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Tialin
|
125 mg/ml
|
V/DCP/18/0031
|
Dechra Regulatory B.V., Nīderlande
|
QJ01XQ01
|
pigs; turkeys; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0031-01 |
|
1 |
ABPE pudele, 1 l |
-
|
| V/DCP/18/0031-02 |
|
1 |
Polietilēna konteiners, 5 l |
-
|
|